Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Long COVID · Post-Acute COVID-19 Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Yuchao Dong, Doctor

    Study Director

    Changhai Hospital